Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

O-002

Supelco

Oxycodone solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Formule empirique (notation de Hill):
C18H21NO4
Numéro CAS:
Poids moléculaire :
315.36
Numéro CE :
Numéro MDL:
Code UNSPSC :
41116107
ID de substance PubChem :
Nomenclature NACRES :
NA.24

Qualité

certified reference material

Niveau de qualité

Forme

liquid

Caractéristiques

Snap-N-Spike®/Snap-N-Shoot®

Conditionnement

ampule of 1 mL

Fabricant/nom de marque

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)

Concentration

1.0 mg/mL in methanol

Technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Application(s)

forensics and toxicology

Format

single component solution

Température de stockage

2-8°C

Chaîne SMILES 

COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O

InChI

1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1

Clé InChI

BRUQQQPBMZOVGD-XFKAJCMBSA-N

Informations sur le gène

human ... OPRM1(4988)

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This Certified Spiking Solution® is suitable for numerous applications in GC/MS or LC/MS testing of oxycodone from clinical toxicology and urine drug testing to forensic analysis. Oxycodone is a semi-synthetic opioid analgesic sold under many trade names including OxyContin® and Percocet® for treatment of moderate to severe pain. Oxycodone is also sold illicitly under street names such as "Roxies," "Blues," and "Perks".

Application


  • OxycoDonesolution in pediatric perioperative care: OxycoDonesolution has been investigated for its compatibility with other perioperative medications in pediatric settings using Y-type connectors, contributing to safe and effective pain management protocols in children (Youssef et al., 2024).

  • Analytical testing of oxycodone: OxycoDonesolution is utilized in advanced analytical techniques, such as substrate spray mass spectrometry, for the detection of oxycoDoneand naloxone in saliva, showcasing its application in rapid and sensitive diagnostic settings (Millán-Santiago et al., 2024).

  • Study on opioid receptor agonist in exercise physiology: Research has explored the interaction of opioid receptor agonists, including oxycodone, with other compounds in modulating physiological responses to exercise, indicating its role in complex physiological studies (Anselmi et al., 2024).

  • Pharmacological evaluation for pain management: OxycoDonesolution is employed in multivalent vaccination strategies against opioid exposure, providing insights into the development of therapeutic interventions aimed at opioid-related disorders (Song et al., 2024).

  • Quantitative analysis of analgesics: Utilizing HPLC-DAD and LC-MS/MS methods, oxycoDonesolution is critical in the simultaneous determination of multiple analgesics in postoperative solutions, highlighting its importance in pharmacokinetic research and drug monitoring (Yao et al., 2024).

Produits recommandés

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Informations légales

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
OxyContin is a registered trademark of Purdue Pharma L.P.
Percocet is a registered trademark of Endo Pharmaceuticals Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Pictogrammes

FlameSkull and crossbonesHealth hazard

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Organes cibles

Eyes,Central nervous system

Code de la classe de stockage

3 - Flammable liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

49.5 °F - closed cup

Point d'éclair (°C)

9.7 °C - closed cup


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Prescrire international, 22(134), 10-11 (2013-02-02)
At high doses of oxycodone, the fixed-dose combination of oxycodone plus naloxone complicates therapeutic management and will likely have lower analgesic efficacy.
Reply to commentary.
Stephen F Butler
The journal of pain : official journal of the American Pain Society, 14(4), 361-362 (2013-04-04)
Raymond E Glazier et al.
Disability and health journal, 6(2), 107-115 (2013-03-20)
Substance abuse (SA) is a grave and pervasive social problem associated with severe personal and social costs that affect persons with disabilities disproportionally. Most previous research has found SA prevalence to be greater among persons with disabilities than among those
Dustin B Stephens et al.
Journal of studies on alcohol and drugs, 74(3), 386-395 (2013-03-16)
Alcohol consumption dramatically increases the risk of liver damage among those with hepatitis C virus (HCV) infection, yet the impact of HCV status disclosure and standard informational counseling on alcohol use among rural drug users remains poorly understood. In this
James P Zacny et al.
Experimental and clinical psychopharmacology, 21(2), 103-111 (2013-02-21)
Two prominent and important risk factors for nonmedical use of prescription opioids (NMUPO) identified in epidemiological studies are smoking status and sex (i.e., there is a greater likelihood of NMUPO in smokers and in men, relative to nonsmokers and women).

Articles

Although both biphenyl and phenyl-hexyl phases can resolve these compounds, the former exhibits excellent peak shape and substantially less silanol-derived ion exchange activity.

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique